← All diseases

Neuromuscular diseases

Early-onset generalized torsion dystonia (DYT1)

An inherited movement disorder. The muscles contract involuntarily, and an arm or leg twists. It usually begins in childhood and does not affect intelligence.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Neuromuscular diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

A change in a gene called TOR1A disrupts communication between the nerve cells that control movement. As a result, the muscles contract involuntarily; this is called dystonia. Symptoms usually begin in one arm or leg. In some people, they spread over time to the trunk and to the other arms and legs.

Which symptoms can occur?

Symptoms usually begin in childhood or the teenage years. They differ greatly from person to person, even within the same family.

  • Involuntary contraction and twisting of an arm or leg (a common first symptom)
  • Cramping of the hand while writing, called writer's cramp
  • The foot turning inward when walking
  • Movements continuing over time even at rest (sometimes)
  • Contractions spreading to the trunk and the other limbs (sometimes)
  • Tremor

How is it diagnosed?

The diagnosis is suspected from a neurological examination. A genetic test shows the change in the TOR1A gene. There is usually no visible structural problem in the brain.

Treatment and care

Treatment aims to ease the symptoms. A movement disorder specialist becomes involved early on. Medicine and deep brain stimulation, a surgery to place a brain pacemaker, are among the options. Physiotherapy and occupational therapy make daily tasks easier. Regular follow-up is important. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

The disease is passed on through dominant inheritance. For each child of a parent with the gene change, the chance of inheriting the gene is 1 in 2. But only about one third of those who inherit the gene develop the disease. Severity can differ within the same family. Genetic counselling explains the risks to the family.

Source: MedlinePlus Genetics: Early-onset isolated dystonia · GeneReviews: DYT-TOR1A

Key facts

How common is it?
Prevalence: 1-9 per 1 000 000 (Europe)
How is it inherited?
Autosomal dominant
When does it usually start?
Adolescence, Adulthood, Childhood
Gene(s) involved
TOR1A, EIF2AK2, SHQ1

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about DYT1 dystonia

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.

See all studies on ClinicalTrials.gov · Joining clinical trials

Neuromuscular diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:256

No separate ICD-11 code; WHO classifies this disease under: 8A02.0Y

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.